Phase 1 first-in-human study of the enhancer of zeste-homolog 2 (EZH2) histone methyl transferase inhibitor E7438

Date 03 March 2015
Event 13th International Congress on Targeted Anticancer Therapies
Session Epigenetics and chaperones
Topics Anticancer agents
Clinical research
Basic Scientific Principles
Therapy
Biological Therapy
Presenter Vincent Ribrag